Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

SUTENT® (sunitinib malate)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

SUTENT® Quick Finder

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the...
Did you find an answer to your question? Yes No

WARNING: HEPATOTOXICITY

Hepatotoxicity may be severe, and in some cases, fatal. Monitor hepatic function and interrupt, dose reduce, or discontinue SUTENT as recommended [see...

Did you find an answer to your question? Yes No

1 INDICATIONS AND USAGE

1.1 Gastrointestinal Stromal Tumor

SUTENT is indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after...

Did you find an answer to your question? Yes No

2 DOSAGE AND ADMINISTRATION

2.1 Recommended Dosage for GIST and Advanced RCC

The recommended dosage of SUTENT for gastrointestinal stromal tumor (GIST) and advanced...

Did you find an answer to your question? Yes No

3 DOSAGE FORMS AND STRENGTHS

Capsules, hard gelatin:

  • 12.5 mg sunitinib: orange cap and orange body, printed with white ink "Pfizer" on the cap and "STN 12.5 mg" on the body.
  • 25 mg sunitinib:...
Did you find an answer to your question? Yes No

4 CONTRAINDICATIONS

None.

Did you find an answer to your question? Yes No

5 WARNINGS AND PRECAUTIONS

5.1 Hepatotoxicity

SUTENT can cause severe hepatotoxicity, resulting in liver failure or death. In the pooled safety population, liver...

Did you find an answer to your question? Yes No

7 DRUG INTERACTIONS

7.1 Effect of Other Drugs on SUTENT

Strong CYP3A4 Inhibitors

...
Did you find an answer to your question? Yes No

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Risk Summary

Based on animal...

Did you find an answer to your question? Yes No

10 OVERDOSAGE

Treatment of overdose with SUTENT should consist of general supportive measures. There is no specific antidote for overdosage with SUTENT. If indicated, elimination of unabsorbed drug should be achieved by...

Did you find an answer to your question? Yes No

11 DESCRIPTION

Sunitinib is a kinase inhibitor present in SUTENT capsules as the malate salt. Sunitinib malate is described chemically as (2S)-2-hydroxybutanedoic acid with ...

Did you find an answer to your question? Yes No

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

Sunitinib is a small molecule that inhibits multiple receptor tyrosine kinases (RTKs), some of which are implicated...

Did you find an answer to your question? Yes No

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

The carcinogenic potential of sunitinib has been evaluated in 2 species: rasH2...

Did you find an answer to your question? Yes No

14 CLINICAL STUDIES

14.1 Gastrointestinal Stromal Tumor

Study 1

Study 1 (NCT#...

Did you find an answer to your question? Yes No

16 HOW SUPPLIED/STORAGE AND HANDLING

SUTENT 12.5 mg capsules are supplied as hard gelatin capsule with orange cap and orange body, printed with white ink "Pfizer" on the cap, "STN 12.5 mg" on the body:

...
Did you find an answer to your question? Yes No
This Medication Guide has been approved by the U.S. Food and Drug Administration.Revised: August 2021  
MEDICATION GUIDE...
Did you find an answer to your question? Yes No

This product's labeling may have been updated. For the most recent prescribing information, please visit http://www.pfizer.com.

...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No

Resources

Pfizer Oncology Together
For questions regarding the Pfizer Oncology Together program, please call (877) 744-5675.
Didn’t find what you were looking for? Contact us.
Report Adverse Event